Antibiotic Resistance of Vibrio cholera Strains Isolated in Kazakhstan
Abstract
About the Authors
Z. A. SagiyevRussian Federation
I. B. Utepova
Russian Federation
R. S. Mussagaliyeva
Russian Federation
S. D. Alybayev
Russian Federation
M. M. Kulbayeva
Russian Federation
A. O. Ismailova
Russian Federation
A. A. Aldibekova
Russian Federation
References
1. Айкимбаев А.М., Аракелян И.С., Машкеев А.К., Поублан Ф., Семиотрочев В.Л., Темиралиева Г.А. Действие интетрикса на холерные вибрионы с комплексной антибиотикоустойчивостью. Здравоохранение Казахстана. - 1994. - № 8. - C. 68
2. Urassa W.K., Mhando Y.B., Mhalu F.S., Mgonja S.J. Antimicrobial susceptibility patterns of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania. East African Med J 2000; 77: 350-353.
3. Waldor M.K., Tschape H., Mekalanos J.J. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and strepromycin in Vibrio cholera O139. J Bacteriol 1996; 178: 14: 4157-4165.
4. Safrin S., Morris J.G., Adams M., Pons V., Jacobs R., Contle J.E. Non - O:1 Vibrio cholerae Bacterimia: Case Report and Review. Rev Infect Dis 1988; 10 (5): 1012-1017.
5. Thungapathra A.M., Sinha K.K., Chaudhuri S.R., Garg P., Ramamurthy T, Nair B.G., Ghosh A. (2002). Occurrence of Antibiotic Resistance Gene Cassettes aac (6)-lb, dfrA5, dfrA12, and ereA2 in Class 1 Integrons in Non O1, Non O139 Vibrio cholerae strains in India. Antimicrob AgentsChemother 2002; 46: 9: 2948-2955.
6. Dalsgaard A., Forslund A., Bodhidatta D., Serichantalergs O., Pitarangsi C., Pang L. Shimadas T., Echeverria P. A. high proportion of V.cholerae isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogeneous non-O1, non-O139 O-serotypes. Epidemiol Infect 1999; 122, 217-226.
7. Albert M.J., Siddique A.K., Islam M.S., Farugue A.S., Ansaruzzaman M., Farugue S.M., Sack R.B. Large outbreak of clinical cholera due to Vibrio cholera non O1 in Bangladesh. Lancet 1993; 341 (8846): 704.
8. Ramamurthy T., Garg S., Sharma R., Bhattacharya S.K., Nair G.B., Shimada T. Emergence of novel strain of Vibrio cholera with epidemic potential in southern and eastern India. Lancet 1993; 341 (8846): 703-704.
9. Washington J.A., Wilson W.R. Erythromycin: a microbial and clinical perspective after 30 years of clinical use. Mayo Clin Proc 1985; 60: 271-278.
10. Lancet, 341, 703-704.
11. Yamamoto T., Nair G.B., Albert J.M., Parodi C.C., Takeda Y. Survey of in vitro susceptibility of Vibrio cholerae O1 and O139 to Antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 1: 241-244.
12. Савельев В. Н., Бабенышев Б. В., Савельева И. В., Васильева О. В., Гусева Л. В., Грижебовский Г. М., Курбанов Ш. X., Асваров Б. М., Батырова Б. А., Дорошенко И. Г., Антоненко А.Д. Чувствительность/устойчивость к антибактериальным препаратам клинических штаммов холерного вибриона Эльтор, выделенных на Кавказе в период седьмой пандемии холеры. Антибиотики и химиотер. - 2010. - № 5. - С. 8- 13
13. Kitoaka M., Miyata S.T., Unterweger D., Pukatzki S. Antibiotic resistance mechanisms of Vibrio cholerae. J Med Microbiol 2011; 60: 397-407.
14. Clinical and Laboratory Standards Institute. M100-S24 Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement (2014), 230.
15. Coyle M.B., Cavalieri S.J., Harbeck R.J., McCarter Y.S., Ortez J.H., Rankin I.D., Sautter R.I., Sharp S.E., Spiegel S.E. Manual of antimicrobial susceptibility testing [American Society for Microbiology], 2005; 232.
16. Venables W.N., Smith D. M., Core R. (2017). Team An Introduction to R Notes on R: A Programming Environment for Data Analysis and Graphics Version 3.4.1, 99.
Review
For citations:
Sagiyev Z.A., Utepova I.B., Mussagaliyeva R.S., Alybayev S.D., Kulbayeva M.M., Ismailova A.O., Aldibekova A.A. Antibiotic Resistance of Vibrio cholera Strains Isolated in Kazakhstan. Antibiot Khimioter = Antibiotics and Chemotherapy. 2018;63(3-4):12-17. (In Russ.)